Persistent high levels of circulating effector memory T cells and anti-nuclear antibodies in metastatic melanoma patients who experience durable CRs to immunotherapy after the cessation of treatment.
2018
e21576Background: Checkpoint blockade therapies have dramatically improved the prognosis for metastatic melanoma patients, with overall response rates reported as high as 35%. These regimens have s...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI